These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 21763765)

  • 1. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S; Iwao Y; Noguchi S; Kimura S; Itai S
    Int J Pharm; 2013 May; 448(1):132-41. PubMed ID: 23524122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
    Sano S; Iwao Y; Kimura S; Noguchi S; Itai S
    Int J Pharm; 2014 Jul; 468(1-2):234-42. PubMed ID: 24709215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Orally Disintegrating Tablets Containing Powdered Tea Leaves with Enriched Levels of Bioactive Compounds by Means of Microwave Irradiation Technique.
    Tanaka H; Iwao Y; Izumikawa M; Sano S; Ishida H; Noguchi S; Itai S
    Chem Pharm Bull (Tokyo); 2016; 64(9):1288-97. PubMed ID: 27581633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
    Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
    Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation design of a novel fast-disintegrating tablet.
    Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K
    Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
    Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocimum Sanctum seeds, a natural superdisintegrant: formulation and evaluation of fast melt tablets of nimesulide.
    Malik K; Arora G; Singh I
    Polim Med; 2012; 42(1):49-59. PubMed ID: 22783733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
    Kawano Y; Ito A; Sasatsu M; Machida Y
    Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
    Otsuka M; Kanai Y; Hattori Y
    J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.
    Goel H; Vora N; Tiwary AK; Rana V
    Pharm Dev Technol; 2009; 14(5):476-84. PubMed ID: 19241220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.